News

Empowering Cancer Patients and their Caregivers: CSC Partners with EO Care for Clinically Guided Cannabis Support

April 24, 2024
|
The EO Team
Cancer Support Community Logo Gilda's Club logo

Cancer Support Community (CSC) has teamed up with EO Care, a leader in clinically guided cannabis health solutions, to provide cancer patients, survivors, and their caregivers with comprehensive support.

With 40% of cancer patients already turning to cannabis for symptom relief, this partnership offers CSC members access to educational materials and personalized guidance on cannabis to ensure its safe and effective use. Led by Dr. Brooke Worster, Director of Supportive Oncology at Jefferson Health and Chief Medical Officer at EO, our specialized expertise ensures that cancer patients receive accurate, personalized information and support through CSC's resources and helpline. This collaboration reflects a crucial step in empowering all those impacted by cancer to make informed decisions about their healthcare journey, providing them with the tools and support needed to navigate their treatment with confidence.

Read the full press release here.

<-  Back to blog
More
News
News

EO Care, Inc. Statement on Cannabinoid Policy Announcements

The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.

Read More
Read More
News

EO Care, Inc. Statement on Proposed Federal Register Change

As the leader in cannabinoid based symptom management for older adults, we applaud the Centers for Medicare & Medicaid Services (CMS) proposal to expand coverage for federally legal, hemp-derived cannabinoid-based products. At EO, we are uniquely positioned to meet the need of this new, covered cannabinoid care market.

Read More
Read More
News

EO Data & Methodology: November 2025 Update

At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.

Read More
Read More